Stock 130A VERITAS IN SILICO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Veritas In Silico Inc.

Equities

130A

JP3155340007

Biotechnology & Medical Research

Market Closed - Japan Exchange
Other stock markets
 11:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
1,152 JPY +3.97% Intraday chart for Veritas In Silico Inc. +11.09% -.--%
07/05 Certain Common Stock of Veritas In Silico Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024. CI
08/02 Veritas In Silico Inc. has completed an IPO in the amount of ¥800 million. CI

Business Summary

Veritas In Silico Inc is a Japan-based company primarily engaged in the pharmaceutical discovery platform business. The main business is small molecule drug discovery targeting messenger ribonucleic acid (mRNA) using the ibVIS platform, which integrates digital technology including in silico ribonucleic acid (RNA) structural analysis technology and drug discovery technology, through joint drug discovery research with pharmaceutical companies to create mRNA-targeted small molecule drugs.

Managers

Managers TitleAgeSince
Shingo Nakamura FOU
 Founder 52 17/16/17
Hiroyuki Matsuoka ADM
 Chief Administrative Officer 56 01/18/01
Takashi Kamimura COO
 Chief Operating Officer 68 01/17/01

Members of the board

Members of the board TitleAgeSince
Takashi Kamimura COO
 Chief Operating Officer 68 01/17/01
Shingo Nakamura FOU
 Founder 52 17/16/17
Kinichiro Kominami BRD
 Director/Board Member 57 01/19/01
Hiroyuki Matsuoka ADM
 Chief Administrative Officer 56 01/18/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 6,487,114 2,861,024 ( 44.10 %) 0 44.10 %

Shareholders

NameEquities%Valuation
Mitsubishi UFJ Capital Co., Ltd.
7.902 %
512,640 7.902 % 6 M ¥

Company contact information

Veritas In Silico Inc.

1-11-1 Nishigotanda Shinagawa-Ku

141-0031, Tokyo

+

http://www.veritasinsilico.com
address Veritas In Silico Inc.(130A)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
VERITAS IN SILICO INC. Stock Veritas In Silico Inc.
-.--% 46.65M
MODERNA, INC. Stock Moderna, Inc.
+43.36% 54.63B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 39.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 11.94B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-11.83% 10.74B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 130A Stock
  4. Company Veritas In Silico Inc.